Associated Papers
Understanding and predicting the functional consequences of missense mutations in BRCA1 and BRCA2.
Aljarf R et al.
Scientific Reports, 2022
35729312 (PubMed )
Supplement: 41598_2022_13508_MOESM2_ESM.xlsx › Sheet1
Detection of germline variants in Brazilian breast cancer patients using multigene panel testing.
Guindalini RSC et al.
Scientific Reports, 2022
35264596 (PubMed )
Supplement: 41598_2022_7383_MOESM3_ESM.xlsx › Planilha1
Clinical implications of germline mutations in breast cancer genes: RECQL.
Bowden AR et al.
Breast Cancer Research and Treatment, 2019
Neoantigens Derived from Recurrently Mutated Genes as Potential Immunotherapy Targets for Gastric Cancer.
Zhou J et al.
Biomed Research International, 2019
Rare missense mutations in RECQL and POLG associate with inherited predisposition to breast cancer.
Tervasmäki A et al.
International Journal of Cancer, 2018
Select a paper to view details